Lumbar disc herniation
Conditions
Interventions
Severe pain - Chinese medicine group:Lumbar paralysis capsule + diclofenac sodium sustained-release tablet simulant
Mild pain - Chinese medicine manipulation group:Full eucommia capsule + lumbar oblique wrench manipulation
Severe pain - Western medicine group:Diclofenac sodium sustained-release tablets + lumbar paralysis capsule simulant
Moderate pain- herbal manipulation group:Lumbar paralysis capsule + lumbar oblique wrench method
Mild pain -manual group:lumbar oblique wrench manipulation
Mild pain - Chinese medicine group:Full eucommia capsule
Moderate pain - Chinese medicine group:Lumbar paralysis capsules
Moderate pain- manual group:lumbar oblique wrench manipulation
Sponsors
Wangjing Hospital, China Academy of Chinese Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: 1. In line with the diagnosis of lumbar disc herniation, CT and MRI confirmed that there is lumbar disc herniation, the clinical symptoms are leg pain extending below the knee, and in line with the imaging corresponding nerve root distribution area; 2. Age 18 to 65 years old (including 18 and 65 years old); 3. Sign the informed consent form; 4. Low back and leg pain VAS = 7.0 points, included in severe; low back and leg pain VAS 0 points, included mild.
Exclusion criteria
Exclusion criteria: 1. Have a history of lumbar spine surgery; 2. Spinal compression fracture, lumbar spondylolisthesis of degree II and above, lumbar isthmus fissure, lumbar spinal stenosis; 3. Spinal tumors; Tuberculosis of the spine; severe osteoporosis (T-=-3.0 or accompanied by osteoporotic fractures); Diabetes mellitus with peripheral neuropathy; 4. Allergy to non-steroidal drugs, traditional Chinese medicine and other related drugs; 5. History of peptic ulcer/bleeding; 6. People at potentially high risk of bleeding such as taking bispecific antibody drugs or coagulation system disorders, such as perioperative patients with coronary artery bypass grafting; 7. Severe skin diseases or skin damage at the waist; 8. Pregnant and lactating women; 9. Severe heart failure, stroke and other serious cardiovascular and cerebrovascular diseases; severe hepatic and renal insufficiency; 10. Damage to the cauda equina nerve, or lower limb muscle strength = grade 3, or continuous reduction of lower limb movement and sensory function; 11. Special populations (blind, deaf, mute, intellectual or psychiatric disabilities, etc.) who are not suitable for participating in clinical research.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The Oswestry Disability Index; | — |
Secondary
| Measure | Time frame |
|---|---|
| Straight leg elevation test angle;x-ray-Imaging Index;CT-Imaging Index;visual analogue scale of lower limbs;Quality of Life Evaluation SF12 Scale;visual analogue scale of waist;MRI-Imaging Index; | — |
Countries
China
Contacts
Public ContactZHU Liguo
Outcome results
None listed